An Open-Label, Non-Randomized Multicenter Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Providing and Maintaining Glycemic Control in Type 2 Diabetic Adults.
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2012
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 04 Dec 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 Dec 2009 Actual patient number (101) added as reported by ClinicalTrials.gov.